DUSP1 and neuroblastoma: Previous studies demonstrated that BCI decreased neuroblastoma cell viability in a dose-dependent and time-dependent manner (Mendell and MacLusky, 2019), although its cytotoxicity appears to be at least partially independent of DUSP1/6 activity (Thompson et al., 2022).